Search

Search Constraints

You searched for: Author/Creator Fogel, Ronald

Search Results

1. Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies. (July 2017)

2. Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study. (January 2022)

3. Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial. Issue 10342 (11th June 2022)

4. Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial. Issue 10292 (19th June 2021)

5. Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials. (May 2018)

6. Corrigendum: Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease. (June 2017)

7. Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease. (October 2017)